Zacks Investment Research on MSN

PacBio wins Basecamp Research deal for Trillion Gene Atlas initiative

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that Basecamp Research has selected its HiFi sequencing technology on the Revio system to support the ...

Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative

PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced that Basecamp Research, a frontier AI lab for therapeutic design, has selected PacBio HiFi ...
Nasdaq

PacBio Stock Up on HiFi Sequencing Adoption for Major SUDC Research

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that its HiFi whole-genome sequencing technology has been adopted as a first-line approach in a major ...
Nasdaq

PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop

MENLO PARK, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the Vega™ system, the company’s first ...
Seeking Alpha

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

MENLO PARK, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has joined the 1000 Genomes Long Read ...
Seeking Alpha

PacBio Completes Sale of Short-Read Sequencing Assets

MENLO PARK, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of select ...

PacBio Announces the Appointment of Chris Gibson to the Board of Directors

Proven experience in leveraging AI in biology will strengthen the board of directors as PacBio develops data tools to maximize the power of HiFi sequencingMENLO PARK, Calif., March 05, 2026 (GLOBE ...
FierceBiotech

PacBio plots budget cuts after DNA sequencing revenue shortfalls

Pacific Biosciences’ stock price dropped more than 40% this morning after disclosing that revenues from its new DNA sequencing machines are expected to fall below expectations, and that the company ...